Jeong Hee Lee
Overview
Explore the profile of Jeong Hee Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Kim J, Kim H, Kang Y
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003505
Triple-negative breast cancer (TNBC) is characterized by aggressive behavior and limited treatment options, necessitating the identification of novel therapeutic targets. In this study, we investigated the clinical significance of connective...
2.
Kim M, Lee J, Lee J, Kim D, Yang J, An H, et al.
Diagnostics (Basel)
. 2023 Nov;
13(22).
PMID: 37998612
Perilipin (PLIN) is a major structural protein located on the surface of lipid droplets. PLIN plays an important role in human metabolism and is associated with metabolic diseases, such as...
3.
Fan D, Yang M, Lee H, Lee J, Kim H
Front Mol Biosci
. 2023 Nov;
10:1265359.
PMID: 37908231
AVEN, an apoptosis and caspase activation inhibitor, has been associated with adverse clinical outcomes and poor prognosis in Acute myeloid leukemia (AML). Targeting AVEN in AML improves apoptosis sensitivity and...
4.
Hong Y, Lee J, Yoon K
Korean J Intern Med
. 2023 Oct;
39(1):194-195.
PMID: 37793984
No abstract available.
5.
Kim M, Lee J, Lee J, Kim D, Yang J, An H, et al.
In Vivo
. 2022 Oct;
36(6):2708-2713.
PMID: 36309388
Background/aim: The neonatal Fc receptor (FcRn) is a major histocompatibility class I-like molecule responsible for the transfer of passive humoral immunity from a mother to her newborn. Recent research revealed...
6.
Kim M, Ko G, Lee J, Lee J, Kim D, Yang J, et al.
In Vivo
. 2021 Apr;
35(3):1549-1553.
PMID: 33910834
Background/aim: Programmed death ligand-1 (PD-L1) and programmed death protein 1 (PD-1) expression levels in many tumors and their correlation with prognosis have been actively studied. However, studies on PD-1 expression...
7.
Kumar A, DSouza S, Uenishi G, Park M, Lee J, Slukvin I
Bio Protoc
. 2021 Mar;
10(13):e3675.
PMID: 33659345
Pluripotent stem cells (PSCs) have the potential to provide homogeneous cell populations of T cells that can be grown at a clinical scale and genetically engineered to meet specific clinical...
8.
Lee J, Choi S, Kang Y
Molecules
. 2021 Feb;
26(3).
PMID: 33530626
Vascular smooth muscle cell (VSMC) phenotype switching from contractile to synthetic is essential for proliferation and migration in vascular pathophysiology. Connective tissue growth factor (CTGF) is a matricellular protein involved...
9.
Koh H, An H, Ko G, Lee J, Lee J, Kim D, et al.
Medicine (Baltimore)
. 2019 Oct;
98(40):e17188.
PMID: 31577709
S100A9 was originally regarded as a regulator of immune response and a mediator of the inflammatory process. Recent studies have suggested that S100A9 expression plays an important role during tumor...
10.
Koh H, An H, Ko G, Lee J, Lee J, Kim D, et al.
In Vivo
. 2019 Jul;
33(4):1103-1108.
PMID: 31280198
Background/aim: Multiple primary malignant tumors are common in patients with renal cell carcinoma. However, reports on the factors that can identify patients with a risk for subsequent primary malignancies have...